Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection.

Yan AWC, Zaloumis SG, Simpson JA, McCaw JM.

PLoS Comput Biol. 2019 Jan 17;15(1):e1006568. doi: 10.1371/journal.pcbi.1006568. eCollection 2019 Jan.

2.

Accounting for Healthcare-Seeking Behaviours and Testing Practices in Real-Time Influenza Forecasts.

Moss R, Zarebski AE, Carlson SJ, McCaw JM.

Trop Med Infect Dis. 2019 Jan 11;4(1). pii: E12. doi: 10.3390/tropicalmed4010012.

3.

Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.

Doan TN, Cao P, Emeto TI, McCaw JM, McBryde ES.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01487-18. doi: 10.1128/AAC.01487-18. Print 2018 Dec.

PMID:
30249697
4.

In Silico Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance.

Zaloumis SG, Cao P, Dini S, Davenport MP, Cromer D, Khoury DS, Fowkes FJI, McCaw JM, Simpson JA.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01292-18. doi: 10.1128/AAC.01292-18. Print 2018 Dec.

PMID:
30249691
5.

Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility.

Farrukee R, Zarebski AE, McCaw JM, Bloom JD, Reading PC, Hurt AC.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01081-18. doi: 10.1128/AAC.01081-18. Print 2018 Nov.

6.

A simple influenza model with complicated dynamics.

Roberts MG, Hickson RI, McCaw JM, Talarmain L.

J Math Biol. 2018 Aug 28. doi: 10.1007/s00285-018-1285-z. [Epub ahead of print]

PMID:
30155777
7.

Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.

Dini S, Zaloumis S, Cao P, Price RN, Fowkes FJI, van der Pluijm RW, McCaw JM, Simpson JA.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01068-18. doi: 10.1128/AAC.01068-18. Print 2018 Nov.

8.

A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination.

Lydeamore MJ, Campbell PT, Regan DG, Tong SYC, Andrews RM, Steer AC, Romani L, Kaldor JM, McVernon J, McCaw JM.

Math Biosci. 2018 Aug 24. pii: S0025-5564(16)30364-9. doi: 10.1016/j.mbs.2018.08.007. [Epub ahead of print]

PMID:
30149021
9.

Within-host modeling of blood-stage malaria.

Khoury DS, Aogo R, Randriafanomezantsoa-Radohery G, McCaw JM, Simpson JA, McCarthy JS, Haque A, Cromer D, Davenport MP.

Immunol Rev. 2018 Sep;285(1):168-193. doi: 10.1111/imr.12697.

PMID:
30129195
10.

The distribution of the time taken for an epidemic to spread between two communities.

Yan AWC, Black AJ, McCaw JM, Rebuli N, Ross JV, Swan AJ, Hickson RI.

Math Biosci. 2018 Sep;303:139-147. doi: 10.1016/j.mbs.2018.07.004. Epub 2018 Jul 7.

PMID:
30089576
11.

Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia.

Lydeamore MJ, Campbell PT, Cuningham W, Andrews RM, Kearns T, Clucas D, Gundjirryirr Dhurrkay R, Carapetis J, Tong SYC, McCaw JM, McVernon J.

Epidemiol Infect. 2018 Jul;146(9):1194-1201. doi: 10.1017/S0950268818001061. Epub 2018 May 8.

PMID:
29734959
12.

Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease.

Wang Z, Zhu L, Nguyen THO, Wan Y, Sant S, Quiñones-Parra SM, Crawford JC, Eltahla AA, Rizzetto S, Bull RA, Qiu C, Koutsakos M, Clemens EB, Loh L, Chen T, Liu L, Cao P, Ren Y, Kedzierski L, Kotsimbos T, McCaw JM, La Gruta NL, Turner SJ, Cheng AC, Luciani F, Zhang X, Doherty PC, Thomas PG, Xu J, Kedzierska K.

Nat Commun. 2018 Feb 26;9(1):824. doi: 10.1038/s41467-018-03243-7.

13.

Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.

Laurie KL, Horman W, Carolan LA, Chan KF, Layton D, Bean A, Vijaykrishna D, Reading PC, McCaw JM, Barr IG.

J Infect Dis. 2018 Jan 30;217(4):548-559. doi: 10.1093/infdis/jix509.

14.

Epidemic forecasts as a tool for public health: interpretation and (re)calibration.

Moss R, Fielding JE, Franklin LJ, Stephens N, McVernon J, Dawson P, McCaw JM.

Aust N Z J Public Health. 2018 Feb;42(1):69-76. doi: 10.1111/1753-6405.12750. Epub 2017 Dec 27.

PMID:
29281169
15.

A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.

Cao P, Klonis N, Zaloumis S, Dogovski C, Xie SC, Saralamba S, White LJ, Fowkes FJI, Tilley L, Simpson JA, McCaw JM.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00618-17. doi: 10.1128/AAC.00618-17. Print 2017 Dec.

16.
17.

A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection.

Cao P, Klonis N, Zaloumis S, Khoury DS, Cromer D, Davenport MP, Tilley L, Simpson JA, McCaw JM.

J Theor Biol. 2017 Oct 7;430:117-127. doi: 10.1016/j.jtbi.2017.07.017. Epub 2017 Jul 18.

PMID:
28728995
18.

Influenza as a trigger for cardiovascular disease: An investigation of serotype, subtype and geographic location.

Pearce DC, McCaw JM, McVernon J, Mathews JD.

Environ Res. 2017 Jul;156:688-696. doi: 10.1016/j.envres.2017.04.024. Epub 2017 May 5.

PMID:
28477579
19.

Corrigendum to ''Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host'' [J.Theor. Biol. 413 (2017) 34-49].

Yan AWC, Cao P, Heffernan JM, McVernon J, Quinn KM, La Gruta NL, Laurie KL, McCaw JM.

J Theor Biol. 2017 Apr 21;419:394. doi: 10.1016/j.jtbi.2017.03.015. No abstract available.

PMID:
28363398
20.

Characterising pandemic severity and transmissibility from data collected during first few hundred studies.

Black AJ, Geard N, McCaw JM, McVernon J, Ross JV.

Epidemics. 2017 Jun;19:61-73. doi: 10.1016/j.epidem.2017.01.004. Epub 2017 Jan 19.

21.

On the Role of CD8+ T Cells in Determining Recovery Time from Influenza Virus Infection.

Cao P, Wang Z, Yan AW, McVernon J, Xu J, Heffernan JM, Kedzierska K, McCaw JM.

Front Immunol. 2016 Dec 20;7:611. doi: 10.3389/fimmu.2016.00611. eCollection 2016.

22.

Model selection for seasonal influenza forecasting.

Zarebski AE, Dawson P, McCaw JM, Moss R.

Infect Dis Model. 2017 Jan 10;2(1):56-70. doi: 10.1016/j.idm.2016.12.004. eCollection 2017 Feb.

23.

Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host.

Yan AW, Cao P, Heffernan JM, McVernon J, Quinn KM, La Gruta NL, Laurie KL, McCaw JM.

J Theor Biol. 2017 Jan 21;413:34-49. doi: 10.1016/j.jtbi.2016.11.008. Epub 2016 Nov 15. Erratum in: J Theor Biol. 2017 Apr 21;419:394.

PMID:
27856216
24.

Periodic solutions in an SIRWS model with immune boosting and cross-immunity.

Leung T, Hughes BD, Frascoli F, McCaw JM.

J Theor Biol. 2016 Dec 7;410:55-64. doi: 10.1016/j.jtbi.2016.08.034. Epub 2016 Aug 27.

PMID:
27575466
25.
26.

Retrospective forecasting of the 2010-2014 Melbourne influenza seasons using multiple surveillance systems.

Moss R, Zarebski A, Dawson P, McCAW JM.

Epidemiol Infect. 2017 Jan;145(1):156-169. Epub 2016 Sep 27.

PMID:
27671159
27.

Model-Informed Risk Assessment and Decision Making for an Emerging Infectious Disease in the Asia-Pacific Region.

Moss R, Hickson RI, McVernon J, McCaw JM, Hort K, Black J, Madden JR, Tran NH, McBryde ES, Geard N.

PLoS Negl Trop Dis. 2016 Sep 23;10(9):e0005018. doi: 10.1371/journal.pntd.0005018. eCollection 2016 Sep.

28.

Turnover of Village Chickens Undermines Vaccine Coverage to Control HPAI H5N1.

Villanueva-Cabezas JP, Campbell PT, McCaw JM, Durr PA, McVernon J.

Zoonoses Public Health. 2017 Feb;64(1):53-62. doi: 10.1111/zph.12282. Epub 2016 Jun 30.

PMID:
27357237
29.

High conservation level of CD8(+) T cell immunogenic regions within an unusual H1N2 human influenza variant.

Komadina N, Quiñones-Parra SM, Kedzierska K, McCaw JM, Kelso A, Leder K, McVernon J.

J Med Virol. 2016 Oct;88(10):1725-32. doi: 10.1002/jmv.24516. Epub 2016 Mar 22.

PMID:
26950895
30.

Forecasting influenza outbreak dynamics in Melbourne from Internet search query surveillance data.

Moss R, Zarebski A, Dawson P, McCaw JM.

Influenza Other Respir Viruses. 2016 Jul;10(4):314-23. doi: 10.1111/irv.12376. Epub 2016 Mar 7.

31.

Heightened self-reactivity associated with selective survival, but not expansion, of naïve virus-specific CD8+ T cells in aged mice.

Quinn KM, Zaloumis SG, Cukalac T, Kan WT, Sng XY, Mirams M, Watson KA, McCaw JM, Doherty PC, Thomas PG, Handel A, La Gruta NL.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1333-8. doi: 10.1073/pnas.1525167113. Epub 2016 Jan 19.

32.

On the extinction probability in models of within-host infection: the role of latency and immunity.

Yan AW, Cao P, McCaw JM.

J Math Biol. 2016 Oct;73(4):787-813. doi: 10.1007/s00285-015-0961-5. Epub 2016 Jan 9.

PMID:
26748917
33.

The effects of demographic change on disease transmission and vaccine impact in a household structured population.

Geard N, Glass K, McCaw JM, McBryde ES, Korb KB, Keeling MJ, McVernon J.

Epidemics. 2015 Dec;13:56-64. doi: 10.1016/j.epidem.2015.08.002. Epub 2015 Sep 2.

34.

Social encounter profiles of greater Melbourne residents, by location--a telephone survey.

Rolls DA, Geard NL, Warr DJ, Nathan PM, Robins GL, Pattison PE, McCaw JM, McVernon J.

BMC Infect Dis. 2015 Nov 2;15:494. doi: 10.1186/s12879-015-1237-9.

35.

Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.

Campbell PT, McCaw JM, McIntyre P, McVernon J.

Vaccine. 2015 Oct 26;33(43):5794-5800. doi: 10.1016/j.vaccine.2015.09.025. Epub 2015 Sep 19.

PMID:
26392008
36.

Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.

Cao P, Yan AW, Heffernan JM, Petrie S, Moss RG, Carolan LA, Guarnaccia TA, Kelso A, Barr IG, McVernon J, Laurie KL, McCaw JM.

PLoS Comput Biol. 2015 Aug 18;11(8):e1004334. doi: 10.1371/journal.pcbi.1004334. eCollection 2015 Aug.

37.

Quantifying relative within-host replication fitness in influenza virus competition experiments.

Petrie SM, Butler J, Barr IG, McVernon J, Hurt AC, McCaw JM.

J Theor Biol. 2015 Oct 7;382:259-71. doi: 10.1016/j.jtbi.2015.07.003. Epub 2015 Jul 15.

PMID:
26188087
38.

Factors associated with transmission of influenza-like illness in a cohort of households containing multiple children.

Brown CR, McCaw JM, Fairmaid EJ, Brown LE, Leder K, Sinclair M, McVernon J.

Influenza Other Respir Viruses. 2015 Sep;9(5):247-54. doi: 10.1111/irv.12331.

39.

Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.

Laurie KL, Guarnaccia TA, Carolan LA, Yan AW, Aban M, Petrie S, Cao P, Heffernan JM, McVernon J, Mosse J, Kelso A, McCaw JM, Barr IG.

J Infect Dis. 2015 Dec 1;212(11):1701-10. doi: 10.1093/infdis/jiv260. Epub 2015 May 5.

40.

Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance.

Dogovski C, Xie SC, Burgio G, Bridgford J, Mok S, McCaw JM, Chotivanich K, Kenny S, Gnädig N, Straimer J, Bozdech Z, Fidock DA, Simpson JA, Dondorp AM, Foote S, Klonis N, Tilley L.

PLoS Biol. 2015 Apr 22;13(4):e1002132. doi: 10.1371/journal.pbio.1002132. eCollection 2015 Apr.

41.

Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.

Bolton KJ, McCaw JM, Brown L, Jackson D, Kedzierska K, McVernon J.

PLoS One. 2015 Mar 26;10(3):e0120138. doi: 10.1371/journal.pone.0120138. eCollection 2015.

42.

Pertussis models to inform vaccine policy.

Campbell PT, McCaw JM, McVernon J.

Hum Vaccin Immunother. 2015;11(3):669-78. doi: 10.1080/21645515.2015.1011575. Review.

43.

A new approach to estimating trends in chlamydia incidence.

Ali H, Cameron E, Drovandi CC, McCaw JM, Guy RJ, Middleton M, El-Hayek C, Hocking JS, Kaldor JM, Donovan B, Wilson DP; Australian chlamydia incidence estimation group.

Sex Transm Infect. 2015 Nov;91(7):513-9. doi: 10.1136/sextrans-2014-051631. Epub 2015 Jan 6.

PMID:
25564675
44.

Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.

Zaloumis SG, Tarning J, Krishna S, Price RN, White NJ, Davis TM, McCaw JM, Olliaro P, Maude RJ, Kremsner P, Dondorp A, Gomes M, Barnes K, Simpson JA.

CPT Pharmacometrics Syst Pharmacol. 2014 Nov 5;3:e145. doi: 10.1038/psp.2014.43.

45.

Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria.

Zaloumis SG, Tarning J, Krishna S, Price RN, White NJ, Davis TM, McCaw JM, Olliaro P, Maude RJ, Kremsner P, Dondorp A, Gomes M, Barnes K, Simpson JA.

CPT Pharmacometrics Syst Pharmacol. 2014 Nov;3(11):1-9. doi: 10.1038/psp.2014.43.

46.

Dynamical crises, multistability and the influence of the duration of immunity in a seasonally-forced model of disease transmission.

Dafilis MP, Frascoli F, McVernon J, Heffernan JM, McCaw JM.

Theor Biol Med Model. 2014 Oct 4;11:43. doi: 10.1186/1742-4682-11-43.

47.

The influence of changing host immunity on 1918-19 pandemic dynamics.

Bolton KJ, McCaw JM, McVernon J, Mathews JD.

Epidemics. 2014 Sep;8:18-27. doi: 10.1016/j.epidem.2014.07.004. Epub 2014 Aug 8.

48.

The dynamical consequences of seasonal forcing, immune boosting and demographic change in a model of disease transmission.

Dafilis MP, Frascoli F, McVernon J, Heffernan JM, McCaw JM.

J Theor Biol. 2014 Nov 21;361:124-32. doi: 10.1016/j.jtbi.2014.07.028. Epub 2014 Aug 5.

PMID:
25106793
49.

Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs.

Simpson JA, Zaloumis S, DeLivera AM, Price RN, McCaw JM.

AAPS J. 2014 Sep;16(5):962-74. doi: 10.1208/s12248-014-9647-y. Epub 2014 Jul 24. Review.

50.

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.

Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, Mcvernon J, Barr IG, Middleton D, Hurt AC.

J Antimicrob Chemother. 2014 Sep;69(9):2458-69. doi: 10.1093/jac/dku146. Epub 2014 May 19.

Supplemental Content

Loading ...
Support Center